All News

Pharmacogenomics looks at how genetic influences affect an individual’s response to therapeutic medications.

Your weekly roundup of the latest news from Drug Topics®.

The approval represents an adjunctive therapy option for adults and pediatric patients older than age 16.

Groups responded quickly in defense of pharmacists’ ability to prescribe Paxlovid through Test to Treat programs.

Your weekly roundup of the latest news from Drug Topics®.

The Big Three all set up group purchasing organizations recently, but some industry observers question the timing of the move and who will benefit.

Your weekly roundup of the latest news from Drug Topics®.

Several cases of liver injury have been identified in phase 3 clinical trials of tolebrutinib.

Your weekly roundup of the latest news from Drug Topics®.

Your weekly roundup of the latest news from Drug Topics®.

Your weekly roundup of the latest news from Drug Topics®.

Your weekly roundup of the latest news from Drug Topics®.

Your weekly roundup of the latest news from Drug Topics®.

The PharmTech Ready training program bridges professional development and training gaps.

Your weekly roundup of the latest news from Drug Topics®.

The rule will take effect January 1, 2024.

Your weekly roundup of the latest news from Drug Topics®.

Your weekly roundup of the latest news from Drug Topics®.

A look at what’s to come in the May issue of Drug Topics®

Your weekly roundup of the latest news from Drug Topics®.

Take a look back at our most popular news from April 2022.

The funds will help identify and reduce health disparities.

Your weekly roundup of the latest news from Drug Topics®.

This can’t-miss event is being held April 30, 2022.

Your weekly roundup of the latest news from Drug Topics®.

Your weekly roundup of the latest news from Drug Topics®.

A look at what’s to come in the April issue of Drug Topics®

Take a look back at our most popular news from March 2022.